Recent Progress and Prospect in Studying Selective Inhibitors Toward Bromodomain Family Members.

Area of Science:

• Epigenetics
• Medicinal Chemistry
• Computational Biology

Background:

• Bromodomain (BRD)-containing proteins regulate gene transcription and chromatin remodeling.
• BRDs interact with acetylated lysine residues, making them key epigenetic targets.
• Developing small-molecule inhibitors for BRDs is a growing area in drug discovery.

Purpose of the Study:

• To review recent breakthroughs in small-molecule BRD inhibitors.
• To discuss the role of computational simulations in BRD inhibitor design.
• To highlight the biological impact and therapeutic potential of BRD inhibitors.

Main Methods:

• Literature review of recent studies on BRD inhibitors.
• Analysis of computational approaches in designing BRD-targeting drugs.
• Synthesis of findings on biological activities and therapeutic applications.

Main Results:

• Significant progress has been made in developing potent and selective small-molecule BRD inhibitors.
• Computational simulations are instrumental in advancing the design and optimization of BRD inhibitors.
• Numerous BRD inhibitors show promising therapeutic potential across various diseases.

Conclusions:

• Small-molecule inhibitors targeting BRD proteins represent a promising therapeutic strategy.
• Continued research in inhibitor design and computational methods will accelerate drug development.
• This review provides guidance for future drug design targeting BRD inhibitors.